SEC 13F Intelligence

Parkman Healthcare Partners LLC / AMGN

Parkman Healthcare Partners LLC’s Amgen Inc Position

Does Parkman Healthcare Partners LLC own Amgen Inc (AMGN)? Not currently — the last reported position was 61.5K shares worth $18M in Q4 2023; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$18M
Q4 2023
Shares
61.5K
% of Portfolio
+2.50%
Quarters Held
4
position exited

Position History AMGN

Reported value by quarter
Q1 ’21: $11MQ1 ’21Q3 ’21: $4MQ3 ’21Q3 ’23: $5MQ3 ’23Q4 ’23: $18MQ4 ’23filingsflow.com
QuarterSharesValue% of Portfolio
Q4 202361.5K$18M+2.50%
Q3 202320.0K$5M+0.98%
Q3 202120.0K$4M+1.08%
Q1 202145.1K$11M+2.60%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Parkman Healthcare Partners LLC’s full portfolio or all institutional holders of AMGN.